Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching

ABSTRACT Objectives Methotrexate (MTX) is recommended as a first-line conventional synthetic disease-modifying antirheumatic drug (csDMARD) for treating rheumatoid arthritis (RA). This retrospective study sought to identify an add-on csDMARD treatment strategy for RA patients with MTX-inadequate res...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Modern rheumatology 2023-04, Vol.33 (3), p.472-480
Hauptverfasser:	Nozaki, Yuji, Oribe, Motohiro, Tomita, Daisuke, Itami, Tetsu, Hayashi, Shinya, Maeda, Toshihisa, Fukuda, Koji, Kuroda, Ryosuke, Funahashi, Keiko, Matsubara, Tsukasa, Kinoshita, Koji, Matsumura, Itaru
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - adverse effects Arthritis, Rheumatoid - drug therapy Drug Therapy, Combination Humans Methotrexate - therapeutic use Propensity Score Retrospective Studies Sulfasalazine - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!